But, that was enough for the investigators to embark on the “ambitious” TRIGR study, the “Trial to Reduce Incidence of Diabetes in Genetically at Risk, a multinational, randomized prospective trial” involving randomizing thousands of newborns across 15 countries, with expected completion in 2017.